Drug Development
IND filed for gel to treat overactive bladder syndrome
Published in Women's Health Weekly, April 14th, 2005
Based on the evidence provided by the company in its pre-IND meeting with the FDA, the company was granted the right to proceed directly into a phase II dose ranging study upon concurrence with the protocol submitted, as well as conduct only a single phase III study.
Jack E. Stover, president and CEO of Antares Pharma, commented, "The submission of Antares Pharma's first proprietary pharmaceutical submission to the FDA is an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Minimal residual disease persists in bone marrow after adjuvant therapy - Endometrial Cancer
Risk in postmenopausal women with asymptomatic endometrial polyps is low - Menopause
NIH panel calls for "demedicalization" of menopause - Obstetrics
Active management of third stage of labor greatly reduces postpartum hemorrhage - Preeclampsia
Study supports use of aspirin in treating pregnancy disorder - Addiction Medicine
Long-term effects of parental alcoholism on women studied - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
